KHURSHEED ANWER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Imunon, Inc.

Filing Date Source Excerpt
2022-01-25 Khursheed Anwer* Includes 365,368 shares of Common Stock underlying options currently exercisable or exercisable within 60 days of January 14, 2022.
2023-04-28 Dr. Khursheed Anwer, age 63, Executive Vice President and Chief Scientific Officer. Compensation is presented in the Summary Compensation Table with total compensation of $678,658 for 2022.

Data sourced from SEC filings. Last updated: 2025-08-30